Immunocore Holdings plc cotiza a 28.35 USD y tiene una capitalización bursátil de $1.5B. En los últimos 12 meses ha facturado $431M con un margen de flujo de caja libre del -3.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable o…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.02 | $0.25 | $-0.60 |
| Estimado | $-0.12 | $0.02 | $-0.26 | $-0.20 |
| Sorpresa | — | -200.0% | +196.2% | -200.0% |
| Métrica | IMCR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 98.7% | 57.0% | +41.7% |
| Operating Margin | -11.3% | -38.6% | +27.3% |
| Net Margin | -8.9% | -33.6% | +24.7% |
| FCF Margin | -3.8% | -13.9% | +10.1% |
| ROE | -9.3% | -40.4% | +31.1% |
| ROA | -3.3% | -32.0% | +28.7% |
| Current Ratio | 4.04 | 2.84 | +1.20 |
| Debt / Equity | — | 0.28 | — |